000 01300 a2200349 4500
005 20250517084245.0
264 0 _c20180123
008 201801s 0 0 eng d
022 _a1095-9130
024 7 _a10.1016/j.ymeth.2016.03.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUrak, Kevin T
245 0 0 _aIn vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs.
_h[electronic resource]
260 _bMethods (San Diego, Calif.)
_c07 2016
300 _a167-74 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
650 0 4 _aAptamers, Nucleotide
_xchemical synthesis
650 0 4 _aBase Sequence
650 0 4 _aDrug Design
650 0 4 _aHigh-Throughput Nucleotide Sequencing
650 0 4 _aHumans
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSELEX Aptamer Technique
650 0 4 _aSequence Analysis, RNA
700 1 _aShore, Sabrina
700 1 _aRockey, William M
700 1 _aChen, Shi-Jie
700 1 _aMcCaffrey, Anton P
700 1 _aGiangrande, Paloma H
773 0 _tMethods (San Diego, Calif.)
_gvol. 103
_gp. 167-74
856 4 0 _uhttps://doi.org/10.1016/j.ymeth.2016.03.003
_zAvailable from publisher's website
999 _c25823524
_d25823524